Radar on Specialty Pharmacy

HHS Importation Efforts Move Ahead, but Questions Remain

Late last month, the Trump administration moved ahead with a proposed rule and draft guidance that could open the door to drug importation. The moves, it contended, would lower U.S. prescription drug prices. But ske...
0 Comments
© 2024 MMIT

Novel New Drugs, 10 Biosimilar Approvals Were 2019 Standouts

While arguably the biggest news within the specialty pharmacy arena in 2019 was the U.S. approval and launch of the $2.1 million gene therapy Zolgensma (onasemnogene abeparvovec-xioi) (RSP 6/19, p. 1), plenty of oth...
0 Comments
© 2024 MMIT

Troubles for Industry Veteran Diplomat Began Few Years Ago

Diplomat Pharmacy, Inc.’s sale to OptumRx (see story, p. 1) will mark the end of a specialty pharmacy that is nearly half a century old. Diplomat began operations in 1975 as a small, regional operation, and, in...
0 Comments
© 2024 MMIT

New FDA Specialty Approvals

✦ Dec. 3: The FDA expanded the label of Tecentriq (atezolizumab) in combination with Abraxane (paclitaxel protein-bound) and carboplatin for the first-line treatment of adults with metastatic non-squamous non-smal...
0 Comments
© 2024 MMIT

News Briefs

✦ Express Scripts and Prime Therapeutics LLC unveiled a partnership by which the former will offer the latter services related to retail pharmacy network and drug manufacturer contracts. Through the three-year dea...
0 Comments
© 2024 MMIT